The coronavirus pandemic forced people to change how they spend money. In some cases, that was due to unfortunate job loss or short-term layoffs and, in others, it was due to the fact that some of the things we spend money on simply weren’t available. It was/is a crisis that forced many people to think about their finances and that’s generally somethings that’s very good for investors. We’re also going to take a look at biotech IPOs and which top-tier company has the most room for growth.